DexCom, Inc. (DXCM)
| Market Cap | 44.74B |
| Revenue (ttm) | 3.80B |
| Net Income (ttm) | 639.30M |
| Shares Out | 397.68M |
| EPS (ttm) | 1.54 |
| PE Ratio | 73.05 |
| Forward PE | 59.85 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,694,495 |
| Open | 112.17 |
| Previous Close | 112.17 |
| Day's Range | 111.00 - 113.11 |
| 52-Week Range | 74.75 - 142.00 |
| Beta | 1.22 |
| Analysts | Strong Buy |
| Price Target | 140.33 (+24.75%) |
| Earnings Date | Jul 25, 2024 |
About DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into t... [Read more]
Financial Performance
In 2023, DexCom's revenue was $3.62 billion, an increase of 24.49% compared to the previous year's $2.91 billion. Earnings were $541.50 million, an increase of 58.70%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for DXCM stock is "Strong Buy." The 12-month stock price forecast is $140.33, which is an increase of 24.75% from the latest price.
News
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will...
Dexcom Expands AID Partnership Into The Netherlands
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced that people living with Type 1 d...
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase its expanding focus on Dexcom CGM us...
New Weight-Loss Drugs and Devices Are Coming This Week
Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Mon...
Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in acc...
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of ...
Dexcom Announces Upcoming Conference Presentation
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the William B...
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is...
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM d...
Will DexCom Offer Better Returns Than 3M Stock?
Given its better prospects, we believe DexCom stock (NASDAQ NASDAQ : DXCM) is a better pick than 3M stock (NYSE: MMM). Although these companies are from different sectors, we compare them because of t...
Dexcom Reports First Quarter 2024 Financial Results
SAN DIEGO--(BUSINESS WIRE)---- $DXCM #dexcom--DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: ...
SLB, DXCM, CRH: The Economy is Relatively Healthy
Economic trends and earnings continue to drive most of the conversations, notes Tyler Ellegard. He discusses the impact upcoming earnings could have on the markets.
MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems With its Remote Care Management Platform
SAN DIEGO--(BUSINESS WIRE)--MD Revolution, the leader in remote care management solutions for health systems and multi-specialty clinics, has partnered with Dexcom to integrate their industry-leading ...
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
Dexcom Publishes Annual Sustainability Report
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its annual Sustainability Report. This repo...
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Management will...
Neutral to Bullish on TTD, DXCM & Bullish on AMZN
The Trade Desk (TTD), Amazon (AMZN), and DexCom (DXCM) are today's big three stocks. Jessica Inskip and Rick Ducat discuss the technical trends, as well as how to trade these names.
Final Trades: SL Green, Palantir and Dexcom
The Investment Committee share their Final Trades.
Dexcom announces its first ever over-the-counter CGM Stelo has been cleared by the FDA
Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor called Stelo has been cleared for use by the FDA.
US FDA clears use of first over-the-counter continuous glucose monitor
The U.S. Food and Drug Administration has cleared the use of Dexcom's device making it the first continuous glucose monitor to be available over the counter, the health regulator said on Tuesday.
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced compelling new clinical eviden...
Tiger Global slashes stakes in Magnificent Seven while piling into semiconductor makers
Tiger Global has slashed its positions in four of the five Magnificent Seven tech stocks that account for almost half of its portfolio, while upping its stake in Amazon.com and piling into semiconduct...
Dexcom beats profit estimates on strong demand for glucose monitors
Glucose monitor maker Dexcom beat analyst estimates for fourth-quarter earnings on Thursday, helped by strong demand for its continuous glucose monitoring (CGM) systems.